Immutep Quarterly Activities Report Q1 FY24; With A Cash And Cash Equivalent Balance As At 30 September 2023 Of Approximately $110.1M
Portfolio Pulse from Benzinga Newsdesk
Immutep reported its Q1 FY24 activities, highlighting a strong cash position of approximately $110.1 million as of 30 September 2023. The company has sufficient capital to reach key milestones for efti and IMP761. Cash receipts from customers in Q1 FY24 were $132k, compared to $16k in Q4 FY23. The net cash used in G&A activities was $1.61 million, while R&D activities used $9.72 million. Total net cash outflows used in operating activities were $12.86 million. The company also paid $328k for the acquisition of Intellectual Property.
October 31, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immutep's Q1 FY24 report shows a strong cash position and sufficient capital to reach key milestones for its products. The company's increased cash receipts and stable G&A expenses indicate good financial management.
Immutep's strong cash position and increased cash receipts indicate a healthy financial status, which is likely to instill confidence in investors and potentially drive the stock price up in the short term. The company's ability to manage its G&A expenses while increasing its R&D activities also demonstrates good financial management, which is a positive signal to the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100